Recent

% | $
Quotes you view appear here for quick access.

Array BioPharma Inc. Message Board

  • russellmmm russellmmm Mar 25, 2013 8:14 AM Flag

    Piper Jaffray Upgrades Array BioPharma

    The company stock was upgraded to an “overweight” rating from “neutral” rating at Piper Jaffray with a price target of $7.00.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • "Piper Jaffray's newfound bullishness on Array BioPharma (ARRY) puts the stock on the brink of a 5-month high as the investment bank expresses optimism about study data due from ARRY later this year. In addition, the company "has several partnering opportunities in 2013 that could bring in nondilutive funding," an always-welcome sentiment for shareholders. Piper, which boost its price target on ARRY to $7 from $4, notes the company finished 2012 with $110M of cash, which it estimates would get ARRY through mid-2014."

      What did the boy cheese say to his cheese girl friend? "Looking gouda!"

      Sentiment: Strong Buy

 
ARRY
5.58-0.19(-3.29%)2:11 PMEDT